Astria Therapeutics

Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.

Launch date

2008

Employees

Market cap

Net debt

-

Enterprise valuation

$219m (Public information from Jun 2024)

Cambridge Massachusetts (HQ)

http://astriatx.com

https://twitter.com/astriatx https://www.linkedin.com/company/catabasis-pharmaceuticals-inc-

Deals in current and previous year:

Quellis Biosciences

Authorizing premium user...